PReDicT project

The objective of the PReDicT Project (Predicting Response to Depression Treatment) is to conduct clinical, health economic and commercial research to validate the clinical performance and to complete the pre-commercial development of the P1vital® PReDicT Test, a novel medical device to improve the treatment and management of depression in clinical practice. On completion of the PReDicT Project, the P1vital® PReDicT Test will be ready for market launch.